|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Comparative value of tumor grade,hormonal receptors, Ki-67, HER-2 and topoisomerase Ⅱ alpha status as predictive markers in breast cancer patients treated with neoadjuvant anthracycline-based chemotherapy显示文摘 | Petit T Wilt M Velten M | 2004 | Eur J Cancer2004，40，2： | 1 |
| 2 | Comparative value of tumour grade, hormonal receptors, Ki-67, HER-2 and topoisomerase II alpha status as predictive markers in breast cancer patients treated with neoadjuvant anthracycline-based chemotherapy显示文摘 | Petit T Wilt M Vehen M | 2004 | Eur J Cancer2004，40，2： | 1 |
| 3 | 13-sitosterol for the treatment of benign prostatic hyperplasia: a systematic review显示文摘 | T J Wilt R Macdonald A Ishant | 1999 | BJU International1999，83，： | 1 |
| 4 | Indications and long-term outcome of treatment of benign tumors: a criticalappraisall显示文摘 | Terkivatan T de Wilt JH de Man RA | 2001 | Arch Surg2001，136，9： | 1 |
| 5 | Indications and long-term outcome of treatment for benign hepatic tumors:a critical appraisal显示文摘 | de Wilt JH de Man RA | 2001 | Arch Surg2001，136，9： | 1 |
| 6 | Determination of multi-properties of residual oils using mid-infrared attenuated total reflection spectroscopy显示文摘 | Wilt B K Welcht W T | 2006 | Fuel2006，85，： | 1 |
| 7 | Comparative value of tumour grade, hormonal receptors, Ki-67, HER-2 and topoisomerase lI alpha status as predictive markers in breast cancer patients treated with neoadjuvant anthracyeline-based chemotherapy 显示文摘 | Petit T Wilt M Velten M | 2004 | Eur J Cancer2004，40，2： | 1 |
| 8 | Management ofchronic hepatitis B 显示文摘 | Wilt TJ Shamliyan T Shaukat A | 2008 | Evid Rep Technol Assess (Full Rep)2008，17，4： | 1 |
| 9 | Radical prostatectomyversus observation for localized prostate cancer 显示文摘 | Wilt T J Brawer M K Jones K W | 2010 | N Engl JMed2010，367，3： | 1 |
| 10 | Comparative value of turaour grade, hormonal receptors, Ki- 67, HER- 2 and topoi- somerase II alpha status as predictive markers in breast cancer patients treated with neoadjuvant anthraeycline-based chemo- therapy显示文摘 | PETIT T WILT M VELTEN M | 2004 | Eur J Cancer2004，40，2： | 1 |
| 11 | Alfuzosin for treatment of lower urinary tract symptoms compatible with benign prostatic hyperplasia: a systematic review of efficacy and adverse effects 显示文摘 | Macdonald R Wilt T J | 2005 | Urology2005，66，4： | 1 |
| 12 | WITHDRAWN : Tamsulosin for benign prostatic hyperplasia 显示文摘 | Wilt T J Macdonald R Rutks I | 2011 | Cochrane Database Syst Rev2011，，9： | 1 |
| 13 | Serenoa repens for benign prostate hyperplasia (Cochrane review) 显示文摘 | Wilt T Ishani A Stark G | 2003 | In The Cochrane Library Issue 1 Oxford : Update Software2003，2003，： | 1 |
| 14 | Endovascular treatment for cerebral aneuysms will replace clipping显示文摘 | | 2003 | J Neurosurg Anesthesiol2003，15，： | 1 |
| 15 | Comparative value of turnout grade, hormonal receptors, Ki - 67, HER - 2 and topoisomerase Ⅱ α status as predictive markers in breast cancer patients treated with neoadjuvant anthracycline - based chemotherapy 显示文摘 | Petit T Wilt M Velten M | 2004 | Eur J Cancer2004，40，2： | 1 |
| 16 | Comparative value of tumor grade,hormaonal receptors,Ki67,HER-2 and topoisomerase 11 alpha status as predictive markers in breast cancer patients treated with neoadjuvant anthracycline-based chemotherapy显示文摘 | Petit T Wilt M Velten M | 2004 | Eur J Cancer2004，40，： | 1 |
| 17 | Inhibition of lymphangiogensis with resulting lymphedema in transgenic mice expressing soluble VEGF receptor-3显示文摘 | Makinen T Jussila L Wilting } | 2001 | Nat Med2001，7，2： | 1 |
| 18 | Comparative value oftumour grade, hormonal receptors, Ki-67, HER-2 and topoi-somerase II alpha status as predictive markers in breast canc-er patients treated with neoadjuvant anthracycline-basedchemotherapy显示文摘 | Petit T Wilt M Velten M | 2004 | Eur J Cancer2004，40，： | 1 |
| 19 | Tamsulosin for treating lower urinary tract symptoms compatible with benign prostatic obstruction: A systematic review of efficacy and adverse effects 显示文摘 | WILT T J MACDONALD R NELSON D | 2002 | J Urol2002，167，1： | 1 |
| 20 | Comparative value of tumour grade, hormonal receptors, Ki-67, HER-2 and topoisomerase 11 alpha status as predictive markers in breast cancer patients treated with neoadjuvant anthracycline-based chemotherapy 显示文摘 | Petit T Wilt M Velten M | 2004 | Eur J Cancer2004，40，2： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员